Join

Compare · MHUA vs WST

MHUA vs WST

Side-by-side comparison of Meihua International Medical Technologies Co. Ltd. (MHUA) and West Pharmaceutical Services Inc. (WST): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both MHUA and WST operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • WST carries a market cap of $29.12B.
  • Over the past year, MHUA is down 73.7% and WST is up 41.7% - WST leads by 115.4 points.
  • WST has hit the wire 4 times in the past 4 weeks while MHUA has been quiet.
  • WST has more recent analyst coverage (15 ratings vs 0 for MHUA).
PerformanceMHUA-73.74%WST+16.13%
2025-04-28+0.00%2025-12-08
MetricMHUAWST
Company
Meihua International Medical Technologies Co. Ltd.
West Pharmaceutical Services Inc.
Price
$7.61-45.80%
$306.12-1.10%
Market cap
-
$29.12B
1M return
-65.53%
+23.98%
1Y return
-73.74%
+41.67%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
2022
News (4w)
0
4
Recent ratings
0
15
MHUA

Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.

WST

West Pharmaceutical Services Inc.

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Latest MHUA

Latest WST